1. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis
   Xuanming Chen et al, 2018, Life Sciences CrossRef
2. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells
   Olfa Khalifa et al, 2023, International Journal of Molecular Sciences CrossRef
3. Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists
   Stergios A. Polyzos et al, 2017, Metabolism CrossRef
4. Citrus depressa Hayata peel ameliorates nonalcoholic fatty liver and modulates the activity of hepatic drug-metabolizing enzymes and transporters in rats fed a high-fat diet
   Mei-Ling Li et al, 2022, Food & Function CrossRef
5. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
   Olfa Khalifa et al, 2022, Scientific Reports CrossRef
6. A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota
   Ping Hao et al, 2024, Frontiers in Veterinary Science CrossRef
7. Simvastatin protects against acetaminophen-induced liver injury in mice
   Huan Liang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
8. Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model
   Graziella Rodrigues et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
9. Oleic acid-induced steatosis model establishment in LMH cells and its effect on lipid metabolism
   Huiqi Song et al, 2023, Poultry Science CrossRef
10. Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells
    Juan Esteban Oyarzún et al, 2020, Molecules CrossRef
11. Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
    Khaoula Errafii et al, 2021, Journal of Translational Medicine CrossRef
12. Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease
    Yi Pan et al, 2023, ACS Applied Bio Materials CrossRef
13. Human-based systems: Mechanistic NASH modelling just around the corner?
    Joost Boeckmans et al, 2018, Pharmacological Research CrossRef
14. A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis
    Marina Garcia‐Macia et al, 2021, Hepatology CrossRef
15. Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study
    Yangqin Chen et al, 2017, Oncotarget CrossRef
16. Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
    Alfredo Smiriglia et al, 2023, iScience CrossRef
17. C-Glycosidic flavone-rich Passiflora incarnata L. leaf extracts decrease body weight and fatty liver in obese mice
    So-Hyun Park et al, 2023, Food Bioscience CrossRef
18. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation
    Zoë J. Huggett et al, 2022, Nutrients CrossRef
19. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets
    Ali Mahmoudi et al, 2024, Journal of Clinical and Experimental Hepatology CrossRef
20. High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
    Jutatip Kaewmalee et al, 2021, Pharmaceuticals CrossRef
21. Protective Effects of Lactic Acid Bacteria Against TLR4 Induced Inflammatory Response in Hepatoma HepG2 Cells Through Modulation of Toll-Like Receptor Negative Regulators of Mitogen-Activated Protein Kinase and NF-κB Signaling
    Paulraj Kanmani et al, 2018, Frontiers in Immunology CrossRef
22. Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy
    Olfa Khalifa et al, 2022, Biomedicines CrossRef
23. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms
    QIAN XU et al, 2016, International Journal of Molecular Medicine CrossRef
24. Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism
    Khaoula Errafii et al, 2022, Biomedicines CrossRef